From The Source

29 May 2024

Healius to sell off Lumus imaging business

2 minute read

The provider confirmed on Monday it would refocus investment towards its pathology and clinical trials division in a bid to recover its losses.

This content is for Health Services Daily subscribers only.
Login or Join Now.

End of content

No more pages to load

New Member Registration Existing member? log in.

You have selected the Trial membership level. change

This membership level is Free

Account Information

Email Address

Password

Confirm Password

First Name

Last Name

What part of the health sector do you work in?

Organisation

Job Title

AHPRA Number

Newsletter Frequency

Daily News

Full Name LEAVE THIS BLANK

Total to pay: Free

All payments subject to GST. If you are an international customer, contact us.

Processing... This can take up to 15 seconds.
You will be redirected once complete.

Healius to sell off Lumus imaging business

Digital inequity made worse by our western lens

Exclusive: Where is Queensland’s best regional hospital?

Redland Hospital report drops too late for patients

How invisible medical groups are powering telehealth’s GLP-1 ‘gold rush’

Orthocell quarterly report

Australian Government response to the Mental Health and Suicide Prevention – Final Report

Australian Government response to the Inquiry into childhood rheumatic diseases – Interim Report

2024 Victorian Honour Roll of Women inductees announced

Union calls for penalties for workers to be scrapped from Aged Care Act – Health Services Union

VAHI: MH and AoD treatment services in Victoria

DoHAC: Restrictive practices in aged care – a last resort

Nyrada gears up for Phase I clinical trials

Rats – and investors – are happy as Nyrada forges ahead with its first human trial

Radiopharm Theranostics (ASX:RAD): Fireside Chat with CEO Riccardo Canevari

Neuren Pharmaceuticals: DAYBUE™ (trofinetide) receives marketing authorization in Canada

New research uncovers Australian women are often reluctant to openly talk about menopause, despite its impact – Astellas Pharma Australia

RACGP celebrates impact of ‘wonderful’ Victorian GPs – Royal Australian College of GPs

Rejection of drug a blow for Australians living with Alzheimer’s disease – Dementia Australia

New Member Registration Existing member? log in.

Account Information

Payment Information We accept all major credit cards

Log in

New Member Registration Existing member? log in.

Account Information

Payment Information We accept all major credit cards